Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Caine mix is a combination of three local anesthetic agents: **benzocaine**, **tetracaine hydrochloride**, and **dibucaine (cinchocaine) hydrochloride**. These are primarily ester- and amide-type local anesthetics which act by blocking **voltage-gated sodium channels** at the neuronal membrane, thereby inhibiting the initiation and conduction of nerve impulses that mediate pain and itching. Caine mix substances are commonly found in topical medications, both over-the-counter and prescription, for the relief of pain, itching, and stinging associated with conditions like cuts, burns, insect bites, hemorrhoids, rashes, and other minor skin irritations. These anesthetics are also present in certain throat sprays, cough syrups, denture products, and hemorrhoidal preparations[1][3][5][6][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on caine mix.